Projects per year
Organisation profile
Organisation profile
The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.
Fingerprint
Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Jang-Yang Chang
- TMU Research Center of Cancer Translational Medicine - University Chair Professor
- Taipei Medical University Hospital - Visiting Staff
Person: Researcher
-
Wei-Chiao Chang
- Department of Clinical Pharmacy - Professor
- Master Program in Applied Epidemiology - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- The Ph.D. Program for Translational Medicine - Joint-Appointment Professor
- Ph.D. Program in Medical Neuroscience - Joint-Appointment Professor
- TMU Research Center of Drug Discovery - Member
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Tsu-Yi Chao
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
Investigation of the Role of Cathepsin S in Regulation of Lysosome and Its Clinical Relevance in Head and Neck Cancer( I )
Chang, J.-Y. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Investigation the Malignant Role of Histamine Receptor H1 (Hrh1) in Head and Neck Squamous Cell Carcinoma and the Potential of Targeting Hrh1 as a Therapeutic Option
Chien, M.-H. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Dissecting a Novel Aspm-Yap1 Regulatory Module of Intestinal Epithelial Regeneration and Tumorigenesis
Tsai, K.K.-C. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
Effects of photobiomodulation therapy for acute radiation dermatitis in patients with cancer: A systematic review and meta‑analysis of real-world evidence
Lin, Y. T., Mou Tung, K., Chiou, J. F., Chen, Y. C. & Hou, W. H., Jan 2025, In: Radiotherapy and Oncology. 202, 110589.Research output: Contribution to journal › Article › peer-review
-
2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside–stimulated dental pulp stem cells-derived exosomes for wound healing and bone regeneration
Lin, T. Y., Huang, T. Y., Chiu, H. C., Chung, Y. Y., Lin, W. C., Lin, H. Y. & Lee, S. Y., 2024, (Accepted/In press) In: Journal of Dental Sciences.Research output: Contribution to journal › Article › peer-review
Open Access -
Anatomical variations in 3D imaging: A case report of a dorsal metacarpal artery anomaly
Chen, S. Y., Chen, W. T., Fong, T. H., Horng, J. L., Chu, C. Y., Yang, H. & Yang, T. C., Nov 30 2024, In: Heliyon. 10, 22, e40106.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H.-J. (Contributor), Lin, Y.-J. (Contributor), Chao, M.-W. (Contributor), Sung, T.-Y. (Creator), Wu, Y.-W. (Creator), Chen, Y.-Y. (Creator), Lin, M.-H. (Contributor), Liou, J.-P. (Creator), Pan, S.-L. (Contributor) & Yang, C.-R. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4350887.v1, https://springernature.figshare.com/collections/The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/4350887/1
Dataset
-
MOESM1 of The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury
Wang, Y.-J. (Contributor), Wong, H. (Contributor), Wu, C.-C. (Contributor), Chiang, Y.-H. (Contributor), Chiu, W.-T. (Contributor), Chen, K.-Y. (Contributor) & Chang, W.-C. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.11302148.v1, https://springernature.figshare.com/articles/MOESM1_of_The_functional_roles_of_IGF-1_variants_in_the_susceptibility_and_clinical_outcomes_of_mild_traumatic_brain_injury/11302148/1
Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset